enVVeno Medical (NVNO) Revenue & Revenue Breakdown
enVVeno Medical Revenue Highlights
Main Segment (Y)
Royalty Income
Main Geography (Y)
Royalty Income
enVVeno Medical Revenue by Period
enVVeno Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $31.24K | -83.25% |
| 2018-12-31 | $186.55K | -55.80% |
| 2017-12-31 | $422.11K | -46.29% |
| 2016-12-31 | $785.91K | 100.00% |
| 2015-12-31 | - | - |
enVVeno Medical generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
enVVeno Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $824.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $31.24K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $31.24K | 2.56% |
| 2018-12-31 | $30.46K | -26.88% |
| 2018-09-30 | $41.66K | -50.02% |
| 2018-06-30 | $83.36K | 168.35% |
| 2018-03-31 | $31.07K | -82.26% |
| 2017-12-31 | $175.12K | 528.13% |
| 2017-09-30 | $27.88K | -28.14% |
| 2017-06-30 | $38.80K | -78.48% |
| 2017-03-31 | $180.31K | -40.86% |
| 2016-12-31 | $304.86K | 3.18% |
| 2016-09-30 | $295.47K | - |
enVVeno Medical generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
enVVeno Medical Revenue Breakdown
enVVeno Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 | Dec 18 |
|---|---|---|
| Royalty Income | $31.24K | $116.15K |
| Contract Research - Related Party | - | $70.40K |
enVVeno Medical's latest annual revenue breakdown by segment (product or service), as of Dec 19: Royalty Income (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 19 | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|
| Royalty Income | $31.24K | $31.24K | $28.06K | $28.06K | $28.96K |
| Contract Research - Related Party | - | - | $2.40K | $13.60K | $54.40K |
enVVeno Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 19: Royalty Income (100.00%).
enVVeno Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 | Dec 18 |
|---|---|---|
| Royalty Income | $31.24K | $116.15K |
| Contract Research - Related Party | - | $70.40K |
enVVeno Medical's latest annual revenue breakdown by geography, as of Dec 19: Royalty Income (100.00%).
Quarterly Revenue by Country
| Country | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| Royalty Income | $31.24K | $28.06K | $28.06K | $28.96K |
| Contract Research - Related Party | - | $2.40K | $13.60K | $54.40K |
enVVeno Medical's latest quarterly revenue breakdown by geography, as of Jun 19: Royalty Income (100.00%).
enVVeno Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.11M |
| AXGN | AxoGen | $159.01M | $48.64M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $126.08M | $30.34M |
| RXST | RxSight | $89.08M | $45.41M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| IRIX | IRIDEX | $51.87M | $11.58M |
| LNSR | LENSAR | $42.16M | $13.54M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| TNON | Tenon Medical | $2.93M | $887.00K |
| AIMD | Ainos | $122.11K | - |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
| NVNO | enVVeno Medical | - | - |